Dyadic International to present at H.C. Wainwright and BioProcess International conferences.
PorAinvest
jueves, 4 de septiembre de 2025, 9:07 am ET1 min de lectura
DYAI--
Hazelton will be speaking at the H.C. Wainwright 27th Annual Global Investment Conference, scheduled for September 8-10, 2025. The webcast link for Dyadic's investor presentation will be available on their website. Additionally, Dyadic will be represented at the BioProcess International BPI East conference, taking place from September 15-18, 2025, and the Sidoti Small Cap Investor Event, which runs from September 17-18, 2025.
Dyadic Applied BioSolutions leverages proprietary microbial platforms to produce recombinant proteins for various markets, including life sciences, food and nutrition, and bio-industrial applications. The company's C1 and Dapibus™ expression systems support flexible, cost-effective manufacturing and are integral to its growing portfolio of commercial and partnered programs.
The management team welcomes the opportunity to connect with attendees at these conferences and has made it easy to request a meeting by reaching out to jlavalley@dyadic.com.
For more information about Dyadic, visit www.dyadic.com.
References:
[1] https://www.marketscreener.com/news/dyadic-to-present-at-investor-conferences-and-bpi-east-ce7d59d8db8cf22d
[2] https://www.morningstar.com/news/globe-newswire/9522610/dyadic-to-present-at-investor-conferences-and-bpi-east
Dyadic International, a biotechnology company focused on scalable production of high-value proteins, announced that Joe Hazelton, its President & Chief Operating Officer, will attend and present at the H.C. Wainwright 27th Annual Global Investment Conference, BioProcess International BPI East, and Sidoti Small Cap Investor Event. Dyadic's management team welcomes the opportunity to connect with investors, analysts, and industry partners during the conferences.
Jupiter, Fla., September 02, 2025 — Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (Nasdaq: DYAI), a global biotechnology company specializing in the scalable production of high-value, precision-engineered functional input proteins, has announced that Joe Hazelton, its President & Chief Operating Officer, will attend and present at several upcoming investor conferences. The company aims to engage with investors, analysts, and industry partners during these events.Hazelton will be speaking at the H.C. Wainwright 27th Annual Global Investment Conference, scheduled for September 8-10, 2025. The webcast link for Dyadic's investor presentation will be available on their website. Additionally, Dyadic will be represented at the BioProcess International BPI East conference, taking place from September 15-18, 2025, and the Sidoti Small Cap Investor Event, which runs from September 17-18, 2025.
Dyadic Applied BioSolutions leverages proprietary microbial platforms to produce recombinant proteins for various markets, including life sciences, food and nutrition, and bio-industrial applications. The company's C1 and Dapibus™ expression systems support flexible, cost-effective manufacturing and are integral to its growing portfolio of commercial and partnered programs.
The management team welcomes the opportunity to connect with attendees at these conferences and has made it easy to request a meeting by reaching out to jlavalley@dyadic.com.
For more information about Dyadic, visit www.dyadic.com.
References:
[1] https://www.marketscreener.com/news/dyadic-to-present-at-investor-conferences-and-bpi-east-ce7d59d8db8cf22d
[2] https://www.morningstar.com/news/globe-newswire/9522610/dyadic-to-present-at-investor-conferences-and-bpi-east
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios